GH Research PLC Share Price
NASDAQ: GHRSGH Research PLC Stock Performance
GH Research PLC Share Price Today
As of 31 October 2026, GH Research PLC's share price is $20.88. The stock opened at $21.33, compared to its previous close of $21.50. During today's trading session, GH Research PLC's share price traded between $20.47 and $21.33, with an average price of $20.90. Over the past 52 weeks, the stock has recorded a high of $31.16 and a low of $12.10. In terms of performance, GH Research PLC's share price has risen by 1.90% over the last six months and is up 46.12% on a year-on-year basis.
GH Research PLC Share Price Chart
GH Research PLC Annual Profit & Loss
All figures in USD
About GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
GH Research PLC Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $23.24 | $20.93 | -10.94% |
Sep 2026 | $27.30 | $23.50 | -17.95% |
Aug 2026 | $27.55 | $28.64 | +1.99% |
Jul 2026 | $26.94 | $28.08 | +4.00% |
Jun 2026 | $24.05 | $27.00 | +12.55% |
May 2026 | $20.29 | $23.99 | +17.08% |
Apr 2026 | $14.62 | $20.49 | +45.42% |
Mar 2026 | $14.57 | $14.09 | -5.18% |
Feb 2026 | $16.01 | $14.86 | -5.41% |
Jan 2026 | $12.83 | $15.71 | +23.80% |
Dec 2025 | $14.91 | $12.69 | -16.62% |
Nov 2025 | $14.41 | $15.22 | +6.51% |